K
Originally published by KBC County NewsSeptember 12, 2026
3w ago
Ozempic, Wegovy introduced in Kenya as diabetes, obesity burden grows

The introduction of Ozempic and Wegovy in Kenya is drawing attention to the country’s growing cardio-metabolic health burden, as healthcare experts call for a more comprehensive approach to the prevention and management of type 2 diabetes, obesity and related conditions. Novo..
✨ Key Highlights
Novo Nordisk has launched Ozempic and Wegovy in Kenya to address the rising burden of type 2 diabetes and obesity, amidst calls for a comprehensive healthcare approach.
- Africa has seen a 142% rise in diabetes prevalence over the last decade.
- Healthcare experts, including Dr Roseline Ngugi, stress the need for early diagnosis and integrated management of cardio-metabolic conditions.
- Emphasis is placed on ensuring the affordability and accessibility of these new treatments for patients.
Continue Reading
Read the complete article from KBC County News
Watch Kenyan Podcasts
What Happens at 3AM? || Dr. Mwaka
Dr. King'ori1:42:12

The Online Kenyan Android App
Kenya's news, briefed daily
Daily Briefs with audio, your topics, and breaking stories.
Get the Kenyan News appFree Android app on Google Play




The Online Kenyan Android App
Take Kenya's news with you
Breaking stories, daily briefs, and the topics you follow - on your phone, free.
Get the Kenyan News appFree Android app on Google Play









